Situationbuilding
Dr Reddy's wins FDA nod for rituximab biosimilar
Coverage is accumulating steadily rather than spiking
◆ Sectors
Biotech
◆ Where
United States
◆ Timeline
- 1 August 2026Dr Reddy's wins FDA nod for rituximab biosimilarpharma.economictimes.indiatimes.com
- 2 August 2026Dr Reddy's Secures US FDA Approval for Rituximab Biosimilar, Expands Biologics Portfoliooutlookbusiness.com
- 3 August 2026Dr. Reddy's Laboratories Receives US FDA Approval For Rituximab Biosimilarsahi.com
- 13 August 2026Fresenius Kabi And Dr. Reddy's Announce FDA Approval Of Rituximab Biosimilarmondaq.com
- 14 August 2026Fresenius Kabi and Dr. Reddy's Announce Rituxan® Biosimilar Zimrixby™ (rituximab-cdxx ...jdsupra.com
◆ Connected developments
Situations Wire finds semantically close to this one. Proximity, not cause.
◆ Share
◆ Wire has not analysed this situation yet
Below is every report Wire has gathered on this event, and the situations it connects to. The deeper analysis — why it happened, what changed, what would prove it wrong — is not written yet, so nothing here claims it.
◆ Evidence
5 reports · 5 domains